Status:

COMPLETED

Effects of Brain Stimulation on Higher-Order Cognition

Lead Sponsor:

University of California, Davis

Conditions:

Schizophrenia

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

The purpose of this study is to better understand the neural correlates of higher-order cognition, both in the healthy brain and in schizophrenia, and to determine how these mechanisms are modulated b...

Eligibility Criteria

Inclusion

  • Participants must be able to sufficiently speak and understand English so as to be able to understand and complete cognitive tasks.
  • All subjects must have the ability to give valid informed consent.
  • Inclusion Criteria for Patients with Schizophrenia Only:
  • Diagnosis of schizophrenia, schizophreniform or schizoaffective disorder
  • No medication changes in the prior month
  • No medication changes anticipated in the upcoming month
  • Stable outpatient or partial hospital status
  • Normal IQ (\>70; IQ will be measured by administering the Wechsler Abbreviated Scale of Intelligence (WASI) test)

Exclusion

  • Pacemakers
  • Implanted electrical (brain and spinal) stimulators
  • Implanted defibrillator
  • Metallic implants
  • Skin damage or skin conditions such as eczema at the sites where electrodes will be placed
  • Hair styles hindering the placement of electrodes
  • Cranial pathologies
  • Head trauma
  • Epilepsy
  • Mental retardation
  • Any known history of neurological disorders (including epilepsy, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), stroke, cerebral palsy, any DSM-5 axis I psychiatric disorder (for healthy control subjects), autism)
  • Uncorrected vision problems that would hinder cognitive testing (this also pertains to subjects with color blindness in tasks where discriminating colored objects/items is necessary for successful performance)
  • Pregnancy
  • Substance dependence in the past six months
  • Substance abuse in the past month

Key Trial Info

Start Date :

May 22 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 31 2025

Estimated Enrollment :

86 Patients enrolled

Trial Details

Trial ID

NCT03814967

Start Date

May 22 2019

End Date

May 31 2025

Last Update

July 29 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Imaging Research Center

Sacramento, California, United States, 95817